ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 120 filers reported holding ENZO BIOCHEM INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $512,000 | -5.2% | 98,602 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $540,000 | +7.8% | 98,602 | +60.3% | 0.01% | +25.0% |
| Q4 2017 | $501,000 | -22.2% | 61,500 | 0.0% | 0.00% | -33.3% |
| Q3 2017 | $644,000 | -17.2% | 61,500 | -12.8% | 0.01% | -14.3% |
| Q2 2017 | $778,000 | +10.8% | 70,500 | -16.0% | 0.01% | 0.0% |
| Q1 2017 | $702,000 | +20.6% | 83,900 | 0.0% | 0.01% | +16.7% |
| Q4 2016 | $582,000 | +36.3% | 83,900 | 0.0% | 0.01% | +50.0% |
| Q3 2016 | $427,000 | – | 83,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,886,771 | $10,219,000 | 13.54% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $18,323,000 | 6.51% |
| Evermore Global Advisors, LLC | 1,730,607 | $6,126,000 | 5.39% |
| VIEX Capital Advisors, LLC | 1,510,401 | $5,347,000 | 3.24% |
| KEMPNER CAPITAL MANAGEMENT INC. | 25,475 | $90,000 | 0.05% |
| RBF Capital, LLC | 250,359 | $886,000 | 0.05% |
| CORRADO ADVISORS, LLC | 19,366 | $69,000 | 0.04% |
| Cutter & CO Brokerage, Inc. | 27,827 | $99,000 | 0.02% |
| Ergoteles LLC | 177,048 | $627,000 | 0.02% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 941,760 | $3,334,000 | 0.02% |